Current Opinion on Pixantrone in the Treatment of Non-Hodgkin B-Cell Lymphoma
Barbara Jezeršek Novaković, Lučka Boltežar, Aleksander NovakovićDivision of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, 1000, SloveniaCorrespondence: Barbara Jezeršek NovakovićDivision of Medical Oncology, Institute of Oncology Ljubljana, Zaloška 2,...
Guardado en:
Autores principales: | Jezeršek Novaković B, Boltežar L, Novaković A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a7a07d97bfa349708902b90ce5f124bc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacies and Toxicities of Seven Chemotherapy Regimens for Advanced Hodgkin Lymphoma
por: Fajun Pei, et al.
Publicado: (2021) -
A Validated HPLC-MS/MS Method for Quantification of Methotrexate and Application for Therapeutic Drug Monitoring in Children and Adults with Non-Hodgkin Lymphoma
por: Feng Z, et al.
Publicado: (2021) -
Genetic Polymorphisms in NLRP3 Inflammasome-Associated Genes in Patients with B-Cell Non-Hodgkin’s Lymphoma
por: Liu ZH, et al.
Publicado: (2021) -
Raoultella ornithinolytica in MALT-type non-Hodgkin Lymphoma
por: Rui Seixas, et al.
Publicado: (2021) -
EPIDEMIOLOGY OF NON-HODGKIN’S LYMPHOMAS IN iRKUTSK REGION
por: E. V. Zubkova, et al.
Publicado: (2012)